FMC Corp. stock (US3024913036): Q1 earnings beat and lowered Q2 guidance

FMC Corp. reported Q1 2026 EPS of -$0.23, beating estimates by $0.16, but issued weaker Q2 guidance amid revenue shortfalls.

FMC Corp. released its Q1 2026 earnings on April 29, 2026, posting an EPS of -$0.23, which surpassed the consensus estimate of -$0.39 by $0.16. Revenue came in at $762.4 million for the quarter. However, the company lowered its Q2 2026 guidance to EPS of $0.16-$0.26 versus consensus of $0.45, and revenue of $850-$900 million against $976.1 million expected, according to MarketBeat as of 05/12/2026.

The stock has faced pressure post-earnings, trading at around $13.08 on NYSE as of recent data, down 2.43%, reflecting investor concerns over the guidance cut. Earlier in July 2025, shares gained 2.18% to $43.21, per StockInvest.us as of 07/25/2025. Next earnings are slated for July 29, 2026.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: FMC Corp.
• Sector/industry: Agricultural chemicals
• Headquarters/country: United States
• Core markets: North America, Europe, Asia
• Key revenue drivers: Crop protection products
• Home exchange/listing venue: NYSE (FMC)
• Trading currency: USD

FMC Corp.: core business model

FMC Corp. develops and manufactures crop protection solutions, including insecticides, herbicides and fungicides for agricultural use. The company operates through its Crop Protection and Plant Health segments, serving farmers and growers globally. Headquartered in Philadelphia, Pennsylvania, FMC focuses on innovation in sustainable agriculture technologies.

With a presence in over 100 countries, FMC Corp. generates the bulk of its revenue from North America, which accounts for a significant portion of US agricultural markets. This exposure ties the company closely to US farming cycles and commodity prices, making it relevant for US investors tracking agribusiness.

Main revenue and product drivers for FMC Corp.

Key products include Rynaxypyr and Cyazypyr active ingredients used in insecticides, alongside biologicals and precision agriculture tools. Q1 2026 revenue of $762.4 million reflected strength in these areas despite seasonal pressures, as reported on April 29, 2026.

Insecticides represent about 50% of sales, with herbicides and fungicides following. The company's pipeline emphasizes reduced-risk chemistries, aligning with regulatory trends in major markets like the US EPA approvals.

Why FMC Corp. matters for US investors

FMC Corp. holds a strong position in the US crop protection market, where it supplies solutions for corn, soy and cotton growers. With NYSE listing, it offers direct exposure to agricultural chemical demand driven by US farm output, which impacts broader commodity indices.

Conclusion

FMC Corp.'s Q1 2026 earnings beat provided some positives, but lowered Q2 guidance highlights ongoing challenges in revenue execution. The stock's volatility reflects sector dynamics, with upcoming earnings on July 29, 2026, as a key watchpoint. Investors monitor agricultural trends amid these developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.